Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Monoclonal antibodies are often linked to alopecia areata cases.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Certain medications can cause serious side effects, so it's important to report them.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

Inflammation is linked to hair loss.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Osteopontin may play a role in alopecia areata, but its levels don't predict treatment success.

Ozonized olive oil reduces swelling but can cause inflammation and hair loss.

IVIG and dupilumab effectively improved symptoms in a child with Netherton syndrome.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Higher inflammation markers are linked to more severe alopecia areata.

Certain N-glycans may help assess hair loss severity in men with female-pattern hair loss.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

IND-Ca ointment effectively reduces inflammation with minimal skin irritation.

Adalimumab may cause severe hair loss in some patients.